Quarterly report pursuant to Section 13 or 15(d)

Equity (Tables)

v3.7.0.1
Equity (Tables)
 3 Months Ended
Mar. 31, 2017
Equity [Abstract]  
Schedule of Proceeds from Initial Public Offering

Public Offering - January 13, 2017    
    Shares     $     $  
Common Shares                  
Base Offering     1,667,000       2,000,400          
Over-Allotment     122,500       147,000          
Gross Proceeds                     2,147,400  
Underwriter/Gunnar Expenses                        
Discount             150,318          
Legal Fees             60,000          
Roadshow             1,783          
Miscellaneous             34,005          
Total                     246,106  
Akers Biosciences Expenses                        
Legal & Accounting             197,813          
Registration/Regulatory             11,437          
Total                     209,250  
Net Proceeds                     1,692,044  

 

    Private Placement - March 30, 2017  
    Shares     $     $  
Common Shares                  
 Base Offering     1,448,400       2,027,760          
Gross Proceeds                     2,027,760  
 Underwriter/Gunnar Expenses                        
  Discount             141,943          
  Legal Fees             50,000          
 Total                     191,943  
 Akers Biosciences Expenses                        
  Legal & Accounting             75,000          
 Total                     75,000  
Net Proceeds                     1,760,817  

Schedule of Reconcilement of Movement of Shares

The following is a reconcilement of the movement of shares of Series A Convertible Preferred stock (“preferred stock”) and common stock:

 

    Authorized     Issued  
    Preferred     Common     Preferred     Common  
    Stock     Stock     Stock     Stock  
Balance at December 31, 2016     50,000,000       500,000,000       -       5,452,545  
                                 
Shares Issued:                                
  January 13, 2017     -       -       -       1,789,500  
  March 27, 2017     -       -       -       160,000  
  March 28, 2017     -       -       -       3,300  
  March 30, 2017     -       -       -       1,448,400  
Balance at March 31, 2017     50,000,000       500,000,000       -       8,853,745